Serveur d'exploration sur la grippe au Canada - Exploration (Accueil)

Index « Keywords » - entrée « Cost-Benefit Analysis (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cost of Illness (MeSH) < Cost-Benefit Analysis (MeSH) < Cost-Benefit Analysis (methods)  Facettes :

List of bibliographic references indexed by Cost-Benefit Analysis (MeSH)

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000004 (2019) Gokul Raj Pullagura ; Nancy M. Waite ; Sherilyn K D. Houle ; Richard Violette ; William W L. WongCost-utility analysis of offering a novel remunerated community pharmacist consultation service on influenza vaccination for seniors in Ontario, Canada.
000035 (2019) Andrew J. Leidner [États-Unis] ; Neil Murthy [États-Unis] ; Harrell W. Chesson [États-Unis] ; Matthew Biggerstaff [États-Unis] ; Charles Stoecker [États-Unis] ; Aaron M. Harris [États-Unis] ; Anna Acosta [États-Unis] ; Kathleen Dooling [États-Unis] ; Carolyn B. Bridges [États-Unis]Cost-effectiveness of adult vaccinations: A systematic review.
000090 (2017) Eon E K. Ting [Canada] ; Beate Sander [Canada] ; Wendy J. Ungar [Canada]Systematic review of the cost-effectiveness of influenza immunization programs.
000096 (2017) Edward W. Thommes [Canada] ; Morgan Kruse [États-Unis] ; Michele Kohli [Canada] ; Rohita Sharma [Canada] ; Stephen G. Noorduyn [Canada]Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
000160 (2016) Debbie L. Becker [Canada] ; Ayman Chit [États-Unis, Canada] ; Carlos A. Diazgranados [États-Unis] ; Michael Maschio [Canada] ; Eddy Yau [Canada] ; Michael Drummond [Royaume-Uni]High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors.
000163 (2016) Corwin A. Robertson [États-Unis] ; Carlos A. Diazgranados [États-Unis] ; Michael D. Decker [États-Unis] ; Ayman Chit [États-Unis, Canada] ; Monica Mercer [États-Unis] ; David P. Greenberg [États-Unis]Fluzone® High-Dose Influenza Vaccine.
000175 (2016) Léon Nshimyumukiza [Canada] ; Xavier Douville [Canada] ; Diane Fournier [Canada] ; Julie Duplantie [Canada] ; Rana K. Daher [Canada] ; Isabelle Charlebois [Canada] ; Jean Longtin [Canada] ; Jesse Papenburg [Canada] ; Maryse Guay [Canada] ; Maurice Boissinot [Canada] ; Michel G. Bergeron [Canada] ; Denis Boudreau [Canada] ; Christian Gagné [Canada] ; François Rousseau [Canada] ; Daniel Reinharz [Canada]Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment.
000221 (2015) P G Van Buynder [Canada] ; S. Konrad [Canada] ; F. Kersteins [Canada] ; E. Preston [Canada] ; P D Brown [Canada] ; D. Keen [Canada] ; N J Murray [Canada]Healthcare worker influenza immunization vaccinate or mask policy: strategies for cost effective implementation and subsequent reductions in staff absenteeism due to illness.
000237 (2015) Edward W. Thommes [Canada] ; Afisi Ismaila [Canada] ; Ayman Chit [Canada] ; Genevieve Meier [Belgique] ; Christopher T. Bauch [Canada]Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
000248 (2015) Ayman Chit [Canada] ; Julie Roiz [Royaume-Uni] ; Samuel Aballea [France]An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model.
000252 (2015) Alison K. Thompson [Canada] ; Maxwell J. Smith ; Christopher W. Mcdougall ; Cécile Bensimon ; Daniel Felipe Perez"With human health it's a global thing": Canadian perspectives on ethics in the global governance of an influenza pandemic.
000473 (2012) Stephanie R. Earnshaw [États-Unis] ; Cheryl L. Mcdade ; Giovanni Zanotti ; Raymond A. Farkouh ; David StruttonCost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.
000488 (2011) Chris Skedgel [Canada] ; Joanne M. Langley ; Noni E. Macdonald ; Jeff Scott ; Shelly McneilAn incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.
000503 (2011) Bohdan Nosyk [Canada] ; Behnam Sharif ; Huiying Sun ; Curtis Cooper ; Aslam H. AnisThe cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.
000555 (2011) David N. Fisman [Canada] ; Ashleigh R. TuiteEstimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada.
000568 (2011) Elizabeth Rolland-Harris ; Martin TepperCost-effectiveness of Ontario's pandemic vaccine program.
000589 (2011) Jennifer A. Pereira [Canada] ; Julie Foisy ; Jeffrey C. Kwong ; Christine L. Heidebrecht ; Susan Quach ; Sherman D. Quan ; Maryse Guay ; Beate SanderA cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns.
000652 (2010) Beate Sander [Canada] ; Chris T. Bauch ; David Fisman ; Robert A. Fowler ; Jeffrey C. Kwong ; Andreas Maetzel ; Allison Mcgeer ; Janet Raboud ; Damon C. Scales ; Marija Zivkovic Gojovic ; Murray KrahnIs a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
000708 (2009) Nicola J. MercerCost analysis of public health influenza vaccine clinics in Ontario.
000914 (2006) Danuta M. Skowronski [Canada] ; John C. Woolcott ; S Aleina Tweed ; Robert C. Brunham ; Fawziah MarraPotential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.
000965 (2005) Nancy A. Risebrough [Canada] ; Susan K. Bowles ; Andrew E. Simor ; Alison Mcgeer ; Paul I. OhEconomic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Cost-Benefit Analysis (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Cost-Benefit Analysis (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeCanadaV4
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cost-Benefit Analysis (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Sat Aug 8 18:52:12 2020. Site generation: Sat Feb 13 16:40:04 2021